Before joining TheStreet in March 2001, Feuerstein covered business software for Upside.com. Prior to that he covered a variety of business beats, including technology and commercial real estate, at the San Francisco Business Times.
Feuerstein graduated from Emory University with a bachelor's degree in political science.
Recent Articles By The Author
Biogen CEO Resigns After Six Years of Boom-and-Bust Leadership
The departure of Biogen's CEO could lead to a sale of the biotech company, or a renewed push to boost its own M&A activities.
Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact
Celgene continues to sprinkle cash around the biotech sector, tying up with smaller companies for first-dibs access to potentially valuable drugs and technologies.
Brainstorm: New ALS Stem Cell Results Support Start of Pivotal Clinical Trial
Brainstorm's NurOwn is a personalized stem cell treatment designed to slow the progression of ALS, a fatal neurodegenerative disease.
XBiotech Colon Cancer Drug Data Deemed Unreliable by European Group
Serious questions about the XBiotech colon cancer drug were raised after the Xylonix presentation at an ESMO cancer meeting on July 2.
Brain Tumor Patient Dies After Ziopharm Gene Therapy Injection
The circumstances surrounding the Ziopharm patient deaths come amid heightened scrutiny of experimental anti-cancer therapies.